| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Ethinylestradiol 5 microgram and norethisterone acetate 1 mg oral tablet |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| difenhydramin 25 milligram och ibuprofen 200 milligram, oral kapsel |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely hydrochlorothiazide 12.5 milligram and metoprolol tartrate 50 milligram/1 each conventional release oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Ethinylestradiol 20 microgram and norethisterone acetate 1 mg oral tablet |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely ethinylestradiol 30 microgram and norethisterone acetate 1.5 milligram/1 each conventional release oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Hydrochlorothiazide 15 mg and methyldopa 250 mg oral tablet |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Homatropine methylbromide 1.5 mg and hydrocodone bitartrate 5 mg oral tablet |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely hydrocodone bitartrate 2.5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| fluoxetinhydroklorid 25 milligram och olanzapin 6 milligram, oral kapsel |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Drospirenone 2 mg and estradiol 1 mg oral tablet |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely omeprazole 40 milligram and sodium bicarbonate 1.1 gram/1 each conventional release oral capsule (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Pyrimethamine 25 mg and sulfadoxine 500 mg oral tablet |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 400 milligram/1 each conventional release oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Glipizide 5 mg and metformin hydrochloride 500 mg oral tablet |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Ibuprofen 400 mg and oxycodone 5 mg oral tablet |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely hydralazine hydrochloride 100 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral capsule (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| eprosartanmesylat 600 milligram och hydroklortiazid 25 milligram, oral tablett |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Levothyroxine sodium 50 microgram and liothyronine sodium 12.5 microgram oral tablet |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Drospirenone 500 microgram and estradiol 1 mg oral tablet |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| fluoxetinhydroklorid 50 milligram och olanzapin 12 milligram, oral kapsel |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| eprosartanmesylat 600 milligram och hydroklortiazid 12,5 milligram, oral tablett |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely hydralazine hydrochloride 50 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral capsule (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely furosemide 40 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Furosemide 20 mg and spironolactone 50 mg oral capsule |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Ethinylestradiol 20 microgram and levonorgestrel 90 microgram oral tablet |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Hydrocodone bitartrate 10 mg and paracetamol 660 mg oral tablet |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Lopinavir 133.3 mg and ritonavir 33.3 mg oral capsule |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Loratadine 10 mg and pseudoephedrine sulfate 240 mg oral tablet |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely ferrous fumarate 305 milligram and folic acid 350 microgram/1 each conventional release oral capsule (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| fluoxetinhydroklorid 50 milligram och olanzapin 6 milligram, oral kapsel |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely ferrous fumarate 322 milligram and folic acid 350 microgram/1 each conventional release oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Hydrochlorothiazide 25 mg and labetalol hydrochloride 300 mg oral tablet |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely glimepiride 1 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely pethidine hydrochloride 50 milligram and promethazine hydrochloride 25 milligram/1 each conventional release oral capsule (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| cyklofosfamid (som cyklofosfamidmonohydrat) 2 gram/injektionsflaska, pulver till injektionsvätska |
har täljarvärde som visar styrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely cefoxitin (as cefoxitin sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
har täljarvärde som visar styrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Amoxicillin (as amoxicillin sodium) 1 g and clavulanic acid (as clavulanate potassium) 200 mg powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Aztreonam 2 g powder for solution for injection vial |
har täljarvärde som visar styrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely aspirin DL-lysine 900 milligram and metoclopramide hydrochloride 10 milligram/1 sachet conventional release oral powder (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely benorilate 2 gram/1 sachet granules for conventional release oral suspension (clinical drug) |
har täljarvärde som visar styrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Deferoxamine mesilate 2 g powder for solution for injection vial |
har täljarvärde som visar styrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely ampicillin (as ampicillin sodium) 250 milligram and flucloxacillin (as flucloxacillin sodium) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| ceftazidim (som ceftazidimpentahydrat) 2 gram/injektionsflaska, pulver till injektionsvätska |
har täljarvärde som visar styrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely ceftriaxone (as ceftriaxone sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
har täljarvärde som visar styrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely cefpirome (as cefpirome sulfate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
har täljarvärde som visar styrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Ifosfamide 2 g powder for solution for injection vial |
har täljarvärde som visar styrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely piperacillin (as piperacillin sodium) 4 gram and tazobactam (as tazobactam sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Dalfopristin (as dalfopristin mesilate) 350 mg and quinupristin (as quinupristin mesilate) 150 mg powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Codeine phosphate 60 mg and paracetamol 1 g effervescent powder for oral suspension sachet |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Remifentanil (as remifentanil hydrochloride) 2 mg powder for solution for injection vial |
har täljarvärde som visar styrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Metoclopramide hydrochloride 5 mg and paracetamol 500 mg effervescent powder for oral suspension sachet |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Raltitrexed 2 mg powder for solution for injection vial |
har täljarvärde som visar styrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| cilastatin (som cilastatinnatrium) 500 milligram/injektionsflaska och imipenem (som imipenemmonohydrat) 500 milligram/injektionsflaska, pulver till injektionsvätska, suspension |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| somatropin (rbe) 2 milligram/spruta, pulver till injektionsvätska |
har täljarvärde som visar styrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely clavulanic acid (as clavulanate potassium) 200 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Magnesium alginate 87.5 mg and sodium alginate 225 mg powder for oral suspension sachet |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Galactose 3.99 g and palmitic acid 4 mg powder for suspension for injection vial |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Mitomycin 2 mg powder for solution for injection vial |
har täljarvärde som visar styrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Piperacillin (as piperacillin sodium) 2 g and tazobactam (as tazobactam sodium) 250 mg powder for solution for injection vial |
har täljarvärde som visar styrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
2 |
| Piperacillin (as piperacillin sodium) 2 g and tazobactam (as tazobactam sodium) 250 mg powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely dantron 10 milligram/1 milliliter and docusate sodium 12 milligram/1 milliliter conventional release oral suspension (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Dihydrocodeine tartrate 2 mg/mL oral solution |
har täljarvärde för koncentrationsstyrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Ferric ammonium citrate 16 mg/mL and folic acid 500 microgram/mL oral solution |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Ferric ammonium citrate 16 mg/mL and folic acid 100 microgram/mL oral solution |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely hydroxyzine hydrochloride 2 milligram/1 milliliter conventional release oral solution (clinical drug) |
har täljarvärde för koncentrationsstyrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Orciprenaline sulfate 2 mg/mL oral solution |
har täljarvärde för koncentrationsstyrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Diazepam 2 mg/mL oral suspension |
har täljarvärde för koncentrationsstyrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| amoxicillin (som amoxicillintrihydrat) 50 milligram/milliliter och klavulansyra (som kaliumklavulanat) 12,5 milligram/milliliter, oral suspension |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Diphenhydramine hydrochloride 2 mg/mL oral solution |
har täljarvärde för koncentrationsstyrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely morphine sulfate 2 milligram/1 milliliter conventional release oral solution (clinical drug) |
har täljarvärde för koncentrationsstyrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL oral suspension |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely prednisolone 2 milligram/1 milliliter conventional release oral solution (clinical drug) |
har täljarvärde för koncentrationsstyrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely paroxetine (as paroxetine hydrochloride) 2 milligram/1 milliliter conventional release oral suspension (clinical drug) |
har täljarvärde för koncentrationsstyrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Dried aluminium hydroxide gel 44 mg/mL and magnesium hydroxide 39 mg/mL oral suspension |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely spironolactone 2 milligram/1 milliliter conventional release oral suspension (clinical drug) |
har täljarvärde för koncentrationsstyrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Dried aluminium hydroxide gel 120 mg/mL and magnesium hydroxide 60 mg/mL oral suspension |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| ampicillin (som ampicillintrihydrat) 25 milligram/milliliter och floxacillin (som magnesiumflukloxacillin) 25 milligram/milliliter, oral suspension |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely methadone hydrochloride 2 milligram/1 milliliter conventional release oral solution (clinical drug) |
har täljarvärde för koncentrationsstyrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Pholcodine 2 mg/mL oral solution |
har täljarvärde för koncentrationsstyrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely periciazine 2 milligram/1 milliliter conventional release oral solution (clinical drug) |
har täljarvärde för koncentrationsstyrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| amoxicillin (som amoxicillintrihydrat) 25 milligram/milliliter och klavulansyra (som kaliumklavulanat) 6,25 milligram/milliliter, oral suspension |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Dicycloverine hydrochloride 2 mg/mL oral solution |
har täljarvärde för koncentrationsstyrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely lopinavir 80 milligram/1 milliliter and ritonavir 20 milligram/1 milliliter conventional release oral solution (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous ointment |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely phenothrin 2 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
har täljarvärde för koncentrationsstyrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Midazolam (as midazolam hydrochloride) 2 mg/mL oral solution |
har täljarvärde för koncentrationsstyrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |
| Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous cream |
räkning av bas i aktiv ingrediens |
False |
2 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely sodium fluoride 2 milligram/1 gram conventional release oromucosal solution (clinical drug) |
har täljarvärde för koncentrationsstyrka |
False |
2 (qualifier value) |
Inferred relationship |
Some |
1 |